Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

XPH ETF Forecast & Price Targets

Compare
See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

XPH Analyst Ratings

Strong Buy
61ConsensusRatings
56Buy5Hold0Sell
Based on the Wall Street analyst consensus for 61 of XPH’s holdings.

XPH 12 Month Forecast

$123.82▲(98.93% Upside)
Based on Wall Street analyst 12-month price targets for 61 of SPDR S&P Pharmaceuticals ETF’s holdings in the last 3 months. The average price target is $123.82 with a high forecast of $186.49 and a low forecast of $80.46. The average price target represents a 98.93% change from the last price of $62.24.
Highest Price Target$186.49Average Price Target$123.82Lowest Price Target$80.46

XPH Stocks With Highest Upside Potential

XPH highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Hold$5.08(1055.30% Upside)
Moderate Buy$32.56(552.42% Upside)
Strong Buy$18.74(491.19% Upside)
Strong Buy$29.50(365.30% Upside)
Strong Buy$24.13(283.55% Upside)

XPH Stocks With Highest Downside Potential

XPH highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Hold$22.17(-15.20% Downside)
Hold$34.79(-4.28% Downside)
Moderate Buy$29.62(0.61% Upside)
Moderate Buy$17.00(5.66% Upside)
Strong Buy$66.00(9.51% Upside)

XPH ETF FAQ

What is XPH’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 61 of XPH’s holdings, SPDR S&P Pharmaceuticals ETF’s 12-month average price target is $123.82.
What is XPH’s upside potential, based on the analysts’ average price target?
XPH’s average price target of $123.82 represents a 98.93% upside from its last price of $62.24.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is XPH a Buy, Sell or Hold?
SPDR S&P Pharmaceuticals ETF has a consensus rating of Strong Buy, based on the analyst consensus for 61 of XPH’s holdings: 56 rated Buy, 5 rated Hold and 0 rated Sell.
What is SPDR S&P Pharmaceuticals ETF’s price target?
The average price target for SPDR S&P Pharmaceuticals ETF is $123.82, based on Wall Street analyst 12-month price targets for 61 of XPH’s holdings, issued in the past 3 months. The highest price target is $186.49 and the lowest is $80.46. The average price target represents a 98.93% increase from the last price of $62.24.
What do analysts say about SPDR S&P Pharmaceuticals ETF?
SPDR S&P Pharmaceuticals ETF’s analyst rating consensus is Strong Buy, based on Wall Street analyst ratings for 61 of XPH’s holdings.
How can I buy shares of XPH?
You can buy shares of XPH through a brokerage account. Compare brokers on our Best Online Brokers page.